Core Scientific, Inc./Tx (CORZ) Stock Price & Analysis

Core Scientific, Inc./Tx (CORZ) fell 5.05% to USD 22.75 as of July 25, 2026 at 02:24 UTC, according to Nexqual real-time market data.

CORZ last closed at USD 23.96; the session ranged USD 22.52–23.69 on volume of 8,099,586 shares. Market capitalization is $7.23B, with a 52-week range of USD 12.6–30.46 (NMS). Source: Nexqual, July 25, 2026 at 02:24 UTC.

Key Statistics (as of July 25, 2026 at 02:24 UTC)

PriceUSD 22.75
Change▼ 5.05% (down)
Previous CloseUSD 23.96
OpenUSD 23.62
Day RangeUSD 22.52 – 23.69
52-Week RangeUSD 12.6 – 30.46
Volume8,099,586 shares
Market Cap$7.23B
ExchangeNMS

Technical Analysis (CORZ)

Nexqual's technical model rates CORZ "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:24 UTC.

Overall SignalSTRONG SELL
RSI (14)45.97 (neutral)
vs SMA50Below (USD 25.37)
MACD-0.71 (negative)

Analyst Ratings (CORZ)

Wall Street analysts rate CORZ "Strong Buy" based on 16 analysts, with a mean price target of USD 33.36 (range USD 27–55), per Nexqual as of July 25, 2026 at 02:24 UTC.

Consensus RatingStrong Buy
Analyst Count16
Mean TargetUSD 33.36
High TargetUSD 55
Low TargetUSD 27
Buy / Hold / Sell15 / 2 / 0

Earnings (CORZ)

Next Earnings Date2026-08-07
EPS EstimateUSD -0.06
Revenue Estimate$134.94M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD -0.11 vs est -0.05 ▼ miss
2025-12-31USD -0.18 vs est -0.12 ▼ miss
2025-09-30USD -0.2 vs est 0.07 ▼ miss
2025-06-30USD 0.07 vs est 0.01 ▲ beat

Source: Nexqual, July 25, 2026 at 02:24 UTC.

Financials & Fundamentals (CORZ)

Total Revenue$354.74M
Revenue Growth (YoY)+44.90%
Gross Margin+21.56%
Operating Margin-18.77%
Profit Margin+0.00%
Current Ratio0.55
Total Cash$1.01B
Total Debt$2.16B
Free Cash Flow$174.97M

Source: Nexqual, July 25, 2026 at 02:24 UTC.

Financial Health Score (CORZ)

Nexqual rates Core Scientific, Inc./Tx's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 02:24 UTC.

GrowthCritical — Revenue -38% YoY (annual), sharp decline
ProfitabilityWeak — Gross margin 22%, operating -19%
Balance SheetMixed — $1.01B cash vs $2.16B debt
Cash FlowStrong — FCF $175M, 55% margin
EfficiencyMixed — No data

Ownership (CORZ)

Insider Ownership+3.35%
Institutional Ownership+123.55%
Shares Outstanding317.89M
Float255.50M
Short % of Float+24.60%

Source: Nexqual, July 25, 2026 at 02:24 UTC.

Leadership (CORZ)

Core Scientific, Inc./Tx is led by Adam Sullivan (age 33), CEO, President & Director, per Nexqual as of July 25, 2026 at 02:24 UTC.

CEO, President & DirectorAdam Sullivan (age 33)
Executive VP & CFOJames P. Nygaard (age 50)
Chief Operating OfficerMatt Brown
Chief Technology OfficerLarry Kom

Major Backers & Investors (CORZ)

Notable institutional backers of Core Scientific, Inc./Tx include Situational Awareness Partners LP, UBS Group AG, Pentwater Capital Management Lp, according to Nexqual as of July 25, 2026 at 02:24 UTC.

Active Investors

InvestorStake
Situational Awareness Partners LP16.36%
UBS Group AG8.03%
Pentwater Capital Management Lp7.82%
Two Seas Capital Lp5.08%
Jericho Capital Asset Management, LP3.69%
Oaktree Capital Management LP2.94%
Fidelity0.9%
American Century Mutual Funds, Inc.-Small Cap Growth Fund0.6%

Index Funds (Passive)

FundStake
Vanguard Group19.37%
BlackRock11.13%

Source: Nexqual, July 25, 2026 at 02:24 UTC.

From Core Scientific, Inc./Tx's Latest SEC 10-K Filing (filed 2026-03-02)

Key Strengths & Strategy (as disclosed to the SEC)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
CIFRCipher Digital Inc.USD 23.15▼ 5.36%
WULFTeraWulf Inc.USD 18.46▼ 5.28%
BTDRBitdeer Technologies GroupUSD 11.56▼ 5.71%
HUTHut 8 Corp.USD 109.99▲ 0.12%
IRENIREN LIMITEDUSD 37.07▼ 10.2%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:24 UTC. This page is informational and not investment advice.